BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

613 related articles for article (PubMed ID: 17392626)

  • 1. The A's and B's of vaccine-preventable hepatitis: improving prevention in high-risk adults.
    Oldfield EC; Keeffe EB
    Rev Gastroenterol Disord; 2007; 7(1):1-21. PubMed ID: 17392626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance for acute viral hepatitis - United States, 2007.
    Daniels D; Grytdal S; Wasley A;
    MMWR Surveill Summ; 2009 May; 58(3):1-27. PubMed ID: 19478727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The underestimated risk of hepatitis A and hepatitis B: benefits of an accelerated vaccination schedule.
    Keystone JS; Hershey JH
    Int J Infect Dis; 2008 Jan; 12(1):3-11. PubMed ID: 17643334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and factors associated with self-reported vaccination rates among US adults at high risk of vaccine-preventable hepatitis.
    Chen H; Cantrell CR
    Curr Med Res Opin; 2006 Dec; 22(12):2489-96. PubMed ID: 17257463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance for acute viral hepatitis--United States, 2006.
    Wasley A; Grytdal S; Gallagher K;
    MMWR Surveill Summ; 2008 Mar; 57(2):1-24. PubMed ID: 18354374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with hepatitis A and B vaccines.
    Davis JP
    Am J Med; 2005 Oct; 118 Suppl 10A():7S-15S. PubMed ID: 16271535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Public health perspective on vaccine-preventable hepatitis: integrating hepatitis A and B vaccines into public health settings.
    Hershey JH; Schowalter L; Bailey SB
    Am J Med; 2005 Oct; 118 Suppl 10A():100S-108S. PubMed ID: 16271550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid and sustained immune response against hepatitis A and B achieved with combined vaccine using an accelerated administration schedule.
    Connor BA; Blatter MM; Beran J; Zou B; Trofa AF
    J Travel Med; 2007; 14(1):9-15. PubMed ID: 17241248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatitis vaccination of adults].
    Jost R
    Schweiz Med Wochenschr; 1998 Jul; 128(27-28):1104-9. PubMed ID: 9691345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunization against viral hepatitis: an obligatory recommendation in consults for sexually transmitted diseases].
    García-Doval I
    Actas Dermosifiliogr; 2007 Mar; 98(2):88-90. PubMed ID: 17397593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost-effectiveness of using hepatitis A/B combined vaccine versus hepatitis B vaccine alone for high-risk heterosexuals.
    Rein DB; Weinbaum CM
    Vaccine; 2008 Oct; 26(42):5331-3. PubMed ID: 18706957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventing hepatitis A and hepatitis B virus infections among men who have sex with men.
    Kahn J
    Clin Infect Dis; 2002 Dec; 35(11):1382-7. PubMed ID: 12439802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of hepatitis A and hepatitis B by vaccination].
    Buisson Y; Meyran M
    Ann Gastroenterol Hepatol (Paris); 1995 Oct; 31(5):306-8; discussion 308-9. PubMed ID: 8572566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vaccines against hepatitis A and B in Chile].
    Valenzuela MT
    Rev Med Chil; 2009 Jun; 137(6):844-51. PubMed ID: 19746289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccine.
    Van Damme P; Van Herck K
    Expert Rev Vaccines; 2004 Jun; 3(3):249-67. PubMed ID: 15176942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.
    Mele A; Tosti ME; Mariano A; Pizzuti R; Ferro A; Borrini B; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
    Clin Infect Dis; 2008 Mar; 46(6):868-75. PubMed ID: 18269332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
    Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of accelerated and rapid schedules for monovalent hepatitis B and combined hepatitis A/B vaccines in children with cancer.
    Köksal Y; Varan A; Aydin GB; Sari N; Yazici N; Yalcin B; Kutluk T; Akyuz C; Büyükpamukçu M
    Pediatr Hematol Oncol; 2007 Dec; 24(8):587-94. PubMed ID: 18092249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Viral hepatitis: preventable illnesses].
    Baumgarten R
    Z Arztl Fortbild Qualitatssich; 1998 Dec; 92(10):677-80. PubMed ID: 10028595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost effectiveness of hepatitis immunization for US college students.
    Jacobs RJ; Saab S; Meyerhoff AS
    J Am Coll Health; 2003 May; 51(6):227-36. PubMed ID: 14510025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.